Medicare Enrolled

Dr. Mia Eloisa Mison, N.P.

Psychiatry · Suwanee, GA
Low-engagement
1490 DISTRIBUTION DR STE 150, Suwanee, GA 30024
6782633080
In practice since 2012 (14 years)
NPI: 1548532203 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mison from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mison? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mison

Dr. Mia Eloisa Mison is a psychiatry specialist in Suwanee, GA, with 14 years of NPI registration.

Between the years covered by Open Payments, Dr. Mison received a total of $8,598 from 28 pharmaceutical and/or device companies across 464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mison is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice $8,598 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,598
Total received (2021-2024)
Avg $2,149/year across 4 years
Top 9% in GA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
464
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,598 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,655
2023
$2,119
2022
$2,170
2021
$1,653

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$538
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$498
Janssen Pharmaceuticals, Inc
$289
IRONSHORE PHARMACEUTICALS INC.
$227
ABBVIE INC.
$196
Alkermes, Inc.
$156
Otsuka America Pharmaceutical, Inc.
$150
Corium, LLC
$141
Axsome Therapeutics, Inc.
$125
Noven Therapeutics, LLC
$104
Tris Pharma Inc
$78
Lundbeck LLC
$54
Vanda Pharmaceuticals Inc.
$35
Tempus AI, Inc
$28
Takeda Pharmaceuticals U.S.A., Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
Top 3 companies account for 49.9% of 2024 payments
All-time payments by company (2021-2024) ›
Alkermes, Inc.
$1,156
ABBVIE INC.
$802
ITI, Inc.
$789
Janssen Pharmaceuticals, Inc
$774
Otsuka America Pharmaceutical, Inc.
$596
Supernus Pharmaceuticals, Inc.
$595
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$498
Lundbeck LLC
$480
Tris Pharma Inc
$376
Corium, LLC
$373
AbbVie Inc.
$296
Takeda Pharmaceuticals U.S.A., Inc.
$275
IRONSHORE PHARMACEUTICALS INC.
$227
Teva Pharmaceuticals USA, Inc.
$202
Sunovion Pharmaceuticals Inc.
$184
Ironshore Pharmaceuticals Inc.
$183
Noven Therapeutics, LLC
$126
Axsome Therapeutics, Inc.
$125
Bausch Health US, LLC
$100
Neurocrine Biosciences, Inc.
$82
Neos Therapeutics, LP
$80
Adlon Therapeutics L.P.
$63
IDORSIA PHARMACEUTICALS US INC
$45
JAZZ PHARMACEUTICALS INC.
$42
EISAI INC.
$40
Vanda Pharmaceuticals Inc.
$35
Tempus AI, Inc
$28
Corium, Inc.
$27
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · Dayvigo · Dyanavel XR · FANAPT · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LYBALVI · QELBREE · QUVIVIQ · Qelbree · Quillivant · REXULTI · SPRAVATO · SUNOSI · TRINTELLIX · UBRELVY · UZEDY · VIVITROL · VRAYLAR · Vivitrol · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for psychiatry in GA.

Looking for a psychiatry specialist in Suwanee?
Compare psychiatrists in the Suwanee area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
525
Per 100K population
54.3
County median income
$84,823
Nearest hospital
EMORY JOHNS CREEK HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mison is a psychiatry specialist, with low-engagement industry engagement in the top 9% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Mison receive payments from pharmaceutical companies?
Yes. Dr. Mison received a total of $8,598 from 28 companies across 464 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Mison) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →